Cinnarizine SR

Cinnarizine SR (Sustained Release)
CLANARIZINE 75  is a medication that belongs to the class of calcium channel blockers and is used primarily to treat vertigo and motion sickness. CLANARIZINE 75  works by blocking the entry of calcium ions into certain cells, thereby reducing the amount of calcium available for certain cellular processes. CLANARIZINE 75 mechanism of action is thought to help reduce the symptoms of vertigo and motion sickness.
The sustained-release formulation of CLANARIZINE 75  means that the medication is released slowly over time, which allows for a more consistent and prolonged effect. This can be beneficial in the treatment of conditions that require ongoing management.
Like any medication, CLANARIZINE 75  can cause side effects in some people. The most common side effects include drowsiness, dry mouth, constipation, and headache. Less commonly, it can cause more serious side effects such as an allergic reaction or irregular heartbeat. It is important to speak with a healthcare provider before taking CLANARIZINE 75  to determine if it is the appropriate treatment for your specific condition and to discuss any potential risks or side effects.
For further information please contact:
info@sterispharma.com